PGI8 An Exploratory Analysis of the Survival Benefits in Commercially Insured Patients with Hepatic Encephalopathy (HE) Treated with Rifaximin versus Lactulose Alone using US Claims Data

Saved in:
Bibliographic Details
Published inValue in health Vol. 24; pp. S95 - S96
Main Authors Burne, R., Volk, M.L., Guerin, A., Shi, S., Joseph, G., Heimanson, Z., Ahmad, M.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.06.2021
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2021.04.498